The IGFBP3 gene makes a protein that carries and controls insulin-like growth factors, which help guide growth, tissue repair, and cell survival. This gene helps your body keep these growth signals more balanced. If the gene does not work properly, growth may be less well regulated, which can contribute to differences in height or, in some situations, a higher chance of certain cancers. Most IGFBP3 variants have little effect on health.
What is a gene?
Genes are sections of DNA that hold instructions your cells can use to make molecules or regulate processes in the body. Some genes provide the instructions for making proteins, the parts of cells that do the work. Others mainly help determine when certain processes happen, where they happen, and how strongly they run. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To explore this topic in more detail, you can find more in LearnHub.
Overview
IGFBP3Gene function
What if the gene works
The IGFBP3 gene helps control how insulin-like growth factors travel in blood and reach tissues. This supports normal growth, repair, and the balance between cell survival and cell turnover.
Risk
What if the gene does not work
Variants in the IGFBP3 gene can weaken growth signaling, which may lead to short stature and slower growth. Milder and more severe variants can influence when growth differences appear and how marked they are.
Treatment
What does that mean for your treatment
No IGFBP3-specific treatment or medication-choice approach is currently established for people with a pathogenic variant in the IGFBP3 gene. The IGFBP3 gene is being studied as a biomarker and possible drug target in some cancers, but this has not changed routine treatment choices.
Gene function
What if the gene works
Healthy growth depends on steady control of insulin-like growth factors, which are signals that help tissues grow and renew. The IGFBP3 gene makes a protein that carries these signals in the blood and helps manage when they are available to cells. This keeps day to day growth messaging more balanced.
The protein from the IGFBP3 gene attaches to insulin-like growth factors, called IGFs, in the bloodstream. This lets the body hold these growth signals in a stable, usable form.
IGFBP3 helps move IGFs through the blood to tissues that use them. This supports a steady supply of growth signals for normal body growth and tissue upkeep.
By holding onto IGFs and releasing them in a controlled way, this protein helps fine tune when cells receive growth messages. This is a key part of how the IGFBP3 gene helps control growth factors in the bloodstream.
IGFBP3 often travels with IGFs and another blood protein called acid-labile subunit. Together they form a larger package that helps these growth signals stay in circulation longer.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body reacts to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works to a greater degree and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the IGFBP3 gene can change how much IGFBP-3 protein a cell makes, how stable the protein is, and how well it is released from the cell or binds its partner growth signals. In practical terms, how IGFBP3 gene variants affect protein function depends on where the DNA change sits and how much it alters the protein’s shape. Milder variants may slightly lower protein levels or binding strength, while more disruptive variants can greatly reduce protein activity or stop a working protein from being made.
How variants are linked to conditions
At present, the IGFBP3 gene does not yet have a broadly confirmed link to a specific inherited health condition, though this can change as research develops. Reports about an IGFBP3 gene variant linked to conditions usually need careful interpretation because most findings have not been established as a clear diagnosis on their own. Anyone with a confirmed IGFBP3-related result should use their doctor’s or genetic counselor’s advice as the main guide for care.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common in the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the IGFBP3 gene itself. IGFBP3 can play a part in growth and disease risk, but these patterns are shaped by many other genes, age, hormones, and everyday health factors.
Inheritance of IGFBP3 variants
There is not yet a broadly confirmed, disease specific inheritance pattern for the IGFBP3 gene, so IGFBP3 gene inheritance is not described in the same clear way as genes linked to a single well defined inherited condition. Research continues to explore how inherited changes in this gene may influence growth related traits and other health features. The IGFBP3 gene is located on chromosome 7, which is an autosome, so you inherit one copy from each parent.
What does my IGFBP3 result mean for my family?
There is not yet a broadly confirmed, condition-specific family inheritance pattern for the IGFBP3 gene. If you have a specific IGFBP3 result and want to understand what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your family history and the exact change found.
Genetic information
Genetic testing
How you find out about variants
Variants in the IGFBP3 gene are found with genetic testing for IGFBP3 variants, usually using a blood sample or cheek swab. A lab reads the DNA code to look for changes in this gene, either on its own or as part of a larger panel. Results may be benign, linked to a condition, or uncertain.
When should I consider getting a genetic test?
There is not yet a broadly established reason to order genetic testing just for the IGFBP3 gene. Testing decisions are usually based on the full picture, including growth concerns, other health findings, and family history, and are best made with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide useful information, but how much it reveals depends on the condition and the specific type of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. That helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences can shape a person’s response to medications. It examines links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can affect both how strongly a drug works and how the body processes it. This information can help support more informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the IGFBP3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding routine medication choices, so questions about side effects, new symptoms, or how well a treatment is working are best discussed with your doctor. Some research has looked at IGFBP3 and response to certain cancer treatments, but this is not part of standard prescribing.
History
Research on the IGFBP3 gene grew out of efforts in the 1970s and 1980s to understand the proteins in blood that carry insulin-like growth factors. Scientists first identified this major binding protein in human serum, then linked it to a specific gene as molecular genetics advanced. Initially understood only through visible traits in laboratory studies, later recognized as tied to a specific gene, IGFBP3 became part of a broader map of the insulin-like growth factor system. From these first observations, research expanded steadily. By the late 1980s and early 1990s, the gene had been cloned and its structure described, which helped standardize the name IGFBP3. Since then, it has mainly been known within endocrinology and cancer research rather than through public awareness.